Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

The Pharmacological Effects of Conjugates of Pharmacologically Active Amines to Complex or Simple Carriers: a New Class of Drug

KENNETH L. MELMON, YACOB WEINSTEIN, HENRY R. BOURNE, TAK POON, GENE SHEARER and NEAL CASTAGNOLI JR.
Molecular Pharmacology September 1976, 12 (5) 701-710;
KENNETH L. MELMON
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, and the Cardiovascular Research Institute, University of California, San Francisco, California 94143; and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YACOB WEINSTEIN
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, and the Cardiovascular Research Institute, University of California, San Francisco, California 94143; and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HENRY R. BOURNE
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, and the Cardiovascular Research Institute, University of California, San Francisco, California 94143; and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAK POON
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, and the Cardiovascular Research Institute, University of California, San Francisco, California 94143; and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GENE SHEARER
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, and the Cardiovascular Research Institute, University of California, San Francisco, California 94143; and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NEAL CASTAGNOLI JR.
Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, and the Cardiovascular Research Institute, University of California, San Francisco, California 94143; and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Conjugation of selected amines to rabbit serum albumin or copolymer carriers (via amide bonds by sp3 C-N bonds generated by reduction of glutaraldehyde-amine Schiff bases) forms compounds that differ chemically from the free hormones. However, when histamine is conjugated to carrier, by either the carbodiimide or the glutaraldehyde sequence, the pharmacological properties of the conjugate resemble those of free histamine in that both stimulate accumulation of adenosine cyclic 3',5'-monophosphate (cAMP) in human leukocytes. Additionally, the effects of the histamine conjugates are blocked by antihistamines but are unaffected by adrenergic blocking agents. Amide conjugates of norepinephrine are inactive, but when this amine is conjugated via glutaraldehyde the resulting conjugate, like norepinephrine, stimulates accumulation of cAMP in leukocytes and is antagonized by the beta adrenergic blocker propranolol. Conjugates of congeners of norepinephrine that possess no beta adrenergic activity (e.g., normetanephrine) are inactive on leukocytes. Conjugates of some amines, such as tryptamine and dopamine, do not mimic the action of the corresponding free amines. In some cases, when the nitrogen moiety of the conjugate is converted from a primary to a secondary amine, the amine is able to interact with native leukocyte receptors (i.e., stimulation of adenylate cyclase occurs and is appropriately blocked by competitive antagonists of the free amine). In other cases, the actions of the conjugates could not have been predicted by knowing the pharmacological effects of the parent amine.

ACKNOWLEDGMENTS The authors acknowledge and appreciate the excellent technical assistance of Ms. Michele Sanda and the editorial assistance of Ms. Emma Ponick.

  • Copyright © 1976 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 12, Issue 5
1 Sep 1976
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Pharmacological Effects of Conjugates of Pharmacologically Active Amines to Complex or Simple Carriers: a New Class of Drug
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Pharmacological Effects of Conjugates of Pharmacologically Active Amines to Complex or Simple Carriers: a New Class of Drug

KENNETH L. MELMON, YACOB WEINSTEIN, HENRY R. BOURNE, TAK POON, GENE SHEARER and NEAL CASTAGNOLI
Molecular Pharmacology September 1, 1976, 12 (5) 701-710;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The Pharmacological Effects of Conjugates of Pharmacologically Active Amines to Complex or Simple Carriers: a New Class of Drug

KENNETH L. MELMON, YACOB WEINSTEIN, HENRY R. BOURNE, TAK POON, GENE SHEARER and NEAL CASTAGNOLI
Molecular Pharmacology September 1, 1976, 12 (5) 701-710;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics